Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69463 

May 1, 1971. DEA has investigated 

Boehringer Ingelheim, Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28507 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated June 17, 2010 and 

published in the Federal Register on 

June 28, 2010, (75 FR 36681), Alltech 

Associates Inc., 2051 Waukegan Road, 

Deerfield, Illinois 60015, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (MDMA) (7405) .............................................................................................................................. I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Bufotenine (7433) ........................................................................................................................................................................................ I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I 

N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I 

1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... I 

1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I 

Dihydromorphine (9145) .............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Methamphetamine (1105) ........................................................................................................................................................................... II 

1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

Phenylacetone (8501) ................................................................................................................................................................................. II 

1-Piperidinocyclohexanecarbo 

nitrile (8603).

II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Ecgonine (9180) .......................................................................................................................................................................................... II 

Meperidine intermediate-B (9233) ............................................................................................................................................................... II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

The company plans to manufacture 

high purity drug standards used for 

analytical applications only in clinical, 

toxicological, and forensic laboratories. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Alltech Associates, Inc. to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Alltech Associates Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

mstockstill on DSKH9S0YB1PROD with NOTICES

69464 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28536 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 8, 2010, 

Noramco Inc., 1440 Olympic Dr., 

Athens, Georgia 30601, made 

application by renewal to the Drug 

Enforcement Administration (DEA) as a 

bulk manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Codeine-N-Oxide (9053) .............. I 

Morphine-N-Oxide (9307) ............. I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Sufentanil (9740) .......................... II 

Carfentanil (9743) ......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must 

be filed no later than January 11, 2011. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28524 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 16, 2009, 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

Aminorex (1585) .......................................................................................................................................................................................... I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Gamma-Hydroxybutyric acid (2010) ............................................................................................................................................................ I 

Methaqualone (2565) .................................................................................................................................................................................. I 

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. I 

N-Hydroxy-3,4-methylendioxyamphetamine (7402) .................................................................................................................................... I 

3,4-Methylendioxy-N-ethylamphetamine (7404) .......................................................................................................................................... I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Bufotenine (7433) ........................................................................................................................................................................................ I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

5-Methoxy-N,N-diisopropyltyptamine (7439) ............................................................................................................................................... I 

N-Benzylpiperazine (7493) .......................................................................................................................................................................... I 

Acetyldihydrocodeine (9051) ....................................................................................................................................................................... I 

Benzylmorphine (9052) ............................................................................................................................................................................... I 

Codeine-N-oxide (9053) .............................................................................................................................................................................. I 

Dihydromorphine (9145) .............................................................................................................................................................................. I 

mstockstill on DSKH9S0YB1PROD with NOTICES